iRECIST and atypical patterns of response to immuno-oncology drugs

With the advent of immunotherapy as one of the keystones of the treatment of our patients with cancer, a number of atypical patterns of response to these agents has been identified. These include pseudoprogression, where the tumor initially shows objective growth before decreasing in size, and hyper...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramon-Patino, Jorge Luis, Schmid, Sabine, Lau, Sally, Seymour, Lesley, Gaudreau, Pierre-Olivier, Li, Janice Juan Ning, Bradbury, Penelope Ann, Calvo, Emiliano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9207898/
https://www.ncbi.nlm.nih.gov/pubmed/35715004
http://dx.doi.org/10.1136/jitc-2022-004849

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9207898/
https://www.ncbi.nlm.nih.gov/pubmed/35715004
http://dx.doi.org/10.1136/jitc-2022-004849

Ejemplares similares